Cytogenetic, molecular, and functional evidence for novel tumor suppressor genes on the long arm of human chromosome 7

Molecular Carcinogenesis

Volumn 15, Issue 3, 1996, Pages 167-175

  Zenklusen, Jean C ^a   Conti, Claudio J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME 7Q; HUMAN; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 7; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASMS;

EID: 0029869325     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199603)15:3<167::AID-MC2>3.0.CO;2-F     Document Type: Review

References (142)

1. Klein G. The approaching era of the tumor suppressor genes. Science 238:1539-1545, 1987
2. Sager R. Genetic suppression of tumor formation. A new frontier in cancer research. Cancer Res 46 1573-1580, 1986.
3. Weinberg RA. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 49:3713-3721, 1989.
4. Hunter T Cooperation between oncogenes. Cell 64:249-270, 1991.
5. Weinberg RA Tumor suppressor genes Science 254.1138-1146, 1991.
6. Barrett JC. Mechanisms of multistep carcinogenesis and carcinogen risk assessment. Environ Health Perspect 100:9-20, 1993.
7. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 9.138-141, 1993.
8. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis Cell 61 759-767, 1990.
9. Bishop JM. Molecular themes in oncogenesis. Cell 64.235-248, 1991.
10. Friend SH, Bernards R, Rogelj S, et al A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma Nature 323:643-646, 1985
11. Arnold A, Kim HG, Gaz RD, et al Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 83:2034-2040, 1989
12. Finlay CA, Hinds PW, Levine AJ Genetics, molecular biology and colorectal cancer Cell 57:1083-1093, 1989.
13. Call KM, Glaser T, Ito CY, et al Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60.509-520, 1990.
14. Fearon ER, Cho KR, Nigro JN, et al Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247 49-56, 1990.
15. Gessler J, Poustka A, Cavenee W, et al Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343:774-778, 1990
16. Wallace MR, Marchuk DA, Andersen AB, et al Type 1 neurofibromatosis gene Identification of a large transcript disrupted in three NF1 patients [Published erratum appears in Science 250.1749, 1990 ] Science 249 181-186, 1990
17. Joslyn G, Carlson M, Thliveris A, et al. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 66:601-613, 1991.
18. Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260.1317-1320, 1993
19. Knudson AG. Antioncogenes and human cancer. Proc Natl Acad Sci USA 90 10914-10921, 1993
20. Conti CJ,Bianchi AB, Navone NM, et al. Tumor suppressor genes in squamous cell carcinoma. Prog Clin Biol Res 376:85-101, 1992
21. Kok K, Hofstra R, Pilz A, et al. A gene in the chromosomal region 3p21 with greatly reduced expression in lung cancer is similar to the gene for ubiquitin-activating enzyme. Proc Natl Acad Sci USA 90.6071-6075, 1993
22. Ma Q, Alder H, Nelson KK, et al. Analysis of the murine All-1 gene reveals conserved domains with human ALL-1 and identifies a motif shared with DNA methyltransferases. Proc Natl Acad Sci USA 90 6350-6354, 1993
23. Knudson AG Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 68.820-823, 1971.
24. Knudson AG. The Ninth Gordon Hamilton-Fairley Memorial Lecture. Hereditary cancers: Clues to mechanisms of carcinogenesis Br J Cancer 59.661-666, 1989.
25. Chen LC, Dollbaum C, Smith HS. Loss of heterozygosity on chromosome 1q in human breast cancer. Proc Natl Acad Sci USA 86:7204-7207, 1989.
26. Dutrillaux B, Gerbault-Seureau M, Zafrani B. Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes. Cancer Cell Genet 49 203-217, 1990
27. Atkin NB, Baker MC. Numerical chromosome changes in 165 malignant tumors. Evidence for a nonrandom distribution of normal chromosomes. Cancer Genet Cytogenet 52.113-121, 1991
28. Callahan R, Cropp CS, Merlo GR, et al. Somatic mutations and human breast cancer Cancer 69:1582-1588, 1992
29. Pandis N, Heim S, Bardi G, Idvall I, Mandahl N, Mitelman F Chromosome analysis of 20 breast carcinomas: Cytogenetic multiclonality and karyotypic-pathologic correlations. Genes Chromosom Cancer 6 51-57, 1993.
30. Limon J, Lundgren R, Elfving P, et al. Double minutes in two primary adenocarcinomas of the prostate. Cancer Genet Cytogenet 39:191-194, 1989.
31. Brothman AR, Peehl DM, Patel AM, McNeal JE Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res 50.3795-3803, 1990.
32. Micale MA, Mohamed A, Sakr W, Powell LJ, Wolman SR Cytogenetics of primary prostatic adenocarcinoma. Clonality and chromosome instability. Cancer Genet Cytogenet 61:165-173, 1992
33. Sandberg AA. Chromosomal abnormalities and related events in prostate cancer. Hum Pathol 23:368-380, 1992.
34. Cowan JM, Beckett MA, Ahmed-Swan S, Weichselbaum RR. Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas. J Natl Cancer Inst 84.793-797, 1992.
35. Rosenblum VLS, Meltzer SJ, Leana CJ, Schwartz S. Cytogenetic studies of primary cultures of esophageal squamous cell carcinoma Cancer Genet Cytogenet 70:127-131, 1993.
36. Lasserre C, Sabatier L. Beaumatin JL, et al Gene dosage and expression, and enzyme activity of thymidine kinase and thymidylate synthase in xenografted colorectal adenocarcinomas. Int J Cancer 56 506-511, 1992
37. Griffin CA, Lazar S, Hamilton SR, et al Cytogenetic analysis of intestinal polyps in polyposis syndromes: Comparison with sporadic colorectal adenomas. Cancer Genet Cytogenet 67:14-20, 1993
38. James CD, Carlbom E, Nordenskjold M, Collins VP, Cavenee WK. Mitotic recombination of chromosome 17 in astrocytomas Proc Natl Acad Sci USA 86-2858-2862, 1989
39. Mori N, Yokota J, Oshimura M, et al Concordant deletions of chromosome 3p and loss of heterozygosity for chromosomes 13 and 17 in small cell lung carcinoma Cancer Res 49:5130-5135, 1989.
40. Bianchi AB, Navone NM, Aldaz CM, Conti CJ. Mitotic recombination as a mechanism for loss of heterozygosity on mouse chromosome 7 in chemically-induced mouse skin tumors. Proc Natl Acad Sci USA 88 7590-7594, 1991.
41. Hansen MF, Cavenee WK Genetics of cancer predisposition Cancer Res 47:5518-5527, 1987.
42. Vogelstein B, Fearon ER, Kern SE, et al. Allelotype of colorectal carcinomas. Science 244-207-211, 1989.
43. Fults D, Pedone C. Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Genes Chromosom Cancer 7.173-177, 1993
44. Bookstein R, Allred DC. Recessive oncogenes Cancer 71.1179-1186, 1993.
45. Zar JH Biostatistical Analysis, Second Edition. McGraw-Hill, Englewood Cliffs, NJ, 1992
46. Foulkes WD, Black DM, Stamp DWH, Solomon E, Trowsdale J Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma. Int J Cancer 54.220-225, 1993.
47. McDonald JD, Daneshvar L, Willert JR, et al. Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma. Genomics 23:229-232, 1994.
48. Billotte J, Shaw PH PCR and cancer. Schweiz Rundsch Med Prax 83:604-608, 1994.
49. Cawkwell L, Lewis FA, Quirke P Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction Br J Cancer 70 813-818, 1994
50. de Souza AP, Allamand V, Richard I, et al. Targeted development of microsatellite markers from inter-Alu amplification of YAC clones. Genomics 19.391-393, 1994.
51. Umbricht CB, Griffin CA, Hawkins AL, et al. High-resolution genomic mapping of the three human replication protein A genes, RPA1, RPA2, and RPA3 Genomics 20:249-257, 1994
52. Zietkiewicz E, Rafalski A, Labuda D Genome fingerprinting by simple sequence repeat (SSR)-anchored polymerase chain reaction amplification. Genomics 20:176-183, 1994.
53. Aaltonen LA, Peltomaki P. Genes involved in hereditary nonpolyposis colorectal carcinoma. Anticancer Res 14:1657-1660, 1994.
54. Parsons R, Li GM, Longley MJ, et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells Cell 75:1227-1236, 1993.
55. Umar A, Boyer JC, Thomas DC, et al. Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J Biol Chem 269-14367-14370, 1994.
56. Chen LC, Kurisu W, Ljung BM, et al. Heterogeneity for allelic loss in human breast cancer. J Natl Cancer Inst 84:506-510, 1992.
57. Devilee P, van den Broek M, Mannens M, et al. Differences in pattern of allelic loss between two common types of adult cancer, breast and colon carcinoma, and Wilms' tumor of childhood, Int J Cancer 147 817-821, 1991.
58. Devilee P, van Vliet M, van Sloun P, et al. Allelotype of human breast carcinoma: A second major site for loss of heterozygosity is on chromosome 6q. Oncogene 6:1705-1711, 1991.
59. Andersen TI, Gaustad A, Ottestad L, et al. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas Genes Chromosom Cancer 4:113-121, 1992.
60. Carter SL, Negrini M, Baffa R, et al Loss of heterozygosity at 11q22-q23 in breast cancer. Cancer Res 54:6270-6274, 1994.
61. Chen LC, Matsumura K, Deng G, et al. Deletion of two separate regions on chromosome 3p in breast cancers Cancer Res 54-3021-3024, 1994.
62. Cleton-Jansen AM, Moerland EW, Kuipers-Dykshoorn NJ, et al. At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer Genes Chromosom Cancer 9:101-107, 1994.
63. Patel U, Grundfest-Broniatowski S, Gupta M, Banerjee S Microsatellite instabilities at five chromosomes in primary breast tumors. Oncogene 9 3695-3700, 1994
64. Carter BS, Ewing CM, Ward WS, et al. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8751-8755, 1990.
65. Isaacs WB, Carter BS. Genetic changes associated with prostate cancer in humans. Cancer Surv 11:15-24, 1991
66. Kunimi K, Bergerheim US, Larssen IL, Ekman P, Collins VP. Allelotyping of human prostatic adenocarcinoma. Genomics 11.530-536, 1991.
67. Miyaki M, Seki M, Okamoto M, et al. Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis. Cancer Res 50:7166-7173, 1990.
68. Cunningham C, Dunlop MG. Genetics of colorectal cancer. Br Med Bull 50:640-655, 1994.
69. Barletta C, Scillato F, Sega FM, Mannella E Genetic alteration in gastrointestinal cancer. A molecular and cytogenetic study. Anticancer Res 13.2325-2329, 1993
70. el Naggar AK, Lee MS, Wang G, et al. Polymerase chain reaction-based restriction fragment length polymorphism analysis of the short arm of chromosome 3 in primary head and neck squamous carcinoma. Cancer 72:881-886, 1993
71. Elder PA, Bell SM, Knowles MA. Deletion of two regions on chromosome 4 in bladder carcinoma Definition of a critical 750kB region at 4p16.3. Oncogene 9:3433-3436, 1994.
72. van der Riet P, Nawroz H, Hruban RH, et al Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res 54:1156-1158, 1994.
73. Yoo GH, Xu HJ, Brennan JA, et al. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res 54:4603-4606, 1994.
74. Adamson R, Jones AS, Field JK. Loss of heterozygosity studies on chromosome 17 in head and neck cancer using microsatellite markers. Oncogene 9:2077-2082, 1994
75. Marshall CJ. Tumor suppressor genes Cell 64:313-326, 1991.
76. Saxon PJ, Srivatsan ER, Stanbridge EJ. Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells. EMBO J 5.3461-3466, 1986.
77. Porteous DJ, Wilkinson MM, Fletcher JM, van Heyningen V Human-mouse hybrids carrying fragments of single human chromosomes selected by tumor growth. Genomics 5:680-684, 1989.
78. Weissman BE, Saxon PJ, Pasquale SR, Jones GR, Geiser AG, Stanbridge EJ. Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. Science 236.175-180, 1987.
79. Oshimura M, Kugoh H, Koi M, et al. Transfer of a normal human chromosome 11 suppresses tumorigenicity of some but not all tumor cell lines. J Cell Biochem 42:135-142, 1990
80. Tanaka K, Oshimura M, Kikuchi R, et al. Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18. Science 247 568-571, 1990
81. Conway K, Morgan D, Phillips KK, Yuspa SH, Weissman BE. Tumorigenic suppression of a human cutaneous squamous cell carcinoma cell line in the nude mouse skin graft assay Cancer Res 52.6487-6495, 1992.
82. Solé F, Woessner S, Florensa L, et al. A new chromosomal anomaly associated with mature B-cell chronic lymphoproliferative disorders: Del(7)(q32) Cancer Genet Cytogenet 65.170-172, 1993
83. Solé F, Prieto F, Badia L, et al Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes. Cancer Genet Cytogenet 64:12-20, 1992.
84. Solé F, Caballin MR, Coll MD, et al. Cytogenetic studies in acute nonlymphocytic leukemia Cancer Genet Cytogenet 60:117-124, 1992
85. Olopade OI, Thangavelu M, Larson RA, et al Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia Blood 80.2873-2882, 1992
86. Mamuris Z, Dumont J, Dutrillaux B, Aunas A. Chromosomal differences between acute nonlymphocytic leukemia in patients with prior solid tumors and prior hematologic malignancies. A study of 14 cases with prior breast cancer Cancer Genet Cytogenet 42:43-50, 1989
87. Shannon KM, Turhan AG, Rogers PC, Kan YW Evidence implicating heterozygous deletion of chromosome 7 in the pathogenesis of familial leukemia associated with monosomy 7. Genomics 14:121-125, 1992.
88. Kibbelaar RE, Mulder JW, Dreef EJ, et al. Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: A comparison of banding and fluorescence in situ hybridization Blood 82:904-913, 1993.
89. Iurlo A, Mecucci C, Van Orshoven A, et al Cytogenetic and clinical investigations in 76 cases with therapy-related leukemia and myelodysplastic syndrome. Cancer Genet Cytogenet 43:227-241, 1989.
90. Flactif M, Lai JL, Preudhomme C, Fenaux P. Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromes. Leukemia 8.1012-1018, 1994.
91. Shannon KM, Watterson J, Johnson P, et al. Monosomy 7 myeloproliferative disease in children with neurofibromatosis type 1: Epidemiology and molecular analysis. Blood 79:1311-1318, 1992.
92. Tiainen M, Kere J, Tammilehto L, Mattson K, Knuutila S Abnormalities of chromosomes 7 and 22 in human malignant pleural mesothelioma: Correlation between Southern blot and cytogenetic analyses Genes Chromosom Cancer 4.176-182, 1992
93. Pirc-Danoewinata H, Chott A, Onderka E, et al. Karyotype and prognosis in non-Hodgkin lymphoma. Leukemia 8:1929-1939, 1994.
94. Hopman AH, Moesker O, Smeets AW, et al. Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization. Cancer Res 51 644-651, 1991.
95. Bigner SH, Mark J, Bigner DD. Cytogenetics of human brain tumors. Cancer Genet Cytogenet 47 141-154, 1990.
96. Lee JS, Pathak S, Hopwood V, et al. Involvement of chromosome 7 in primary lung tumor and nonmalignant normal lung tissue. Cancer Res 47.6349-6352, 1987.
97. Bardi G, Johansson B, Pandis N, et al. Trisomy 7 in short-term cultures of colorectal adenocarcinomas. Genes Chromosom Cancer 3:149-152, 1992.
98. Wolman SR, Waldman FM, Balazs M. Complementarity of interphase and metaphase chromosome analysis in human renal tumors Genes Chromosom Cancer 6:17-23, 1993.
99. Limon J, Mrózek K, Heim S, et al. On the significance of trisomy 7 and sex chromosome loss in renal cell carcinoma Cancer Genet Cytogenet 49:259-263, 1990
100. Ljungberg B, Nordenson I, Roos G. Cytogenetic and flow cytometric DNA analysis in renal cell carcinoma. Eur Urol 19:59-64, 1991.
101. Maloney KE, Norman RW, Lee CL, Millard OH, Welch JP Cytogenetic abnormalities associated with renal cell carcinoma. J Urol 146:692-696, 1991
102. Presti JC Jr, Rao PH, Chen Q, et al Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res 51:1544-1552, 1991.
103. Casalone R, Granata Casalone P, Minelli E, et al Significance of the clonal and sporadic chromosome abnormalities in non-neoplastic renal tissue Hum Genet 90:71-78, 1992
104. Herrmann ME, Lalley PA Significance of trisomy 7 in thyroid tumors. Cancer Genet Cytogenet 62:144-149, 1992
105. Belge G, Thode B, Rippe V, Bartnitzke S, Bullerdiek J. A characteristic sequence of trisomies starting with trisomy 7 in benign thyroid tumors. Hum Genet 94.198-202, 1994.
106. Babu VR, Miles BJ, Cerny JC, Weiss L, van Dyke DL. Cytogenetic study of four cancers of the prostate. Cancer Genet Cytogenet 48 83-87, 1990.
107. Lundgren R, Mandahl N, Heim S, et al. Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosom Cancer 4.16-24, 1992.
108. Henke RP, Kruger E, Ayhan N, Hubner D, Hammerer P. Frequency and distribution of numerical chromosomal aberrations in prostatic cancer. Hum Pathol 25:476-484, 1994
109. Takahashi S, Qian J, Brown JA, et al. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res 54:3574-3579, 1994.
110. Bandyk MG, Zhao L, Troncoso P, et al Trisomy 7: A potential cytogenetic marker of human prostate cancer progression. Genes Chromosom Cancer 9:19-27, 1994
111. Aldaz CM, Trono D, Larcher F, Slaga TJ, Conti CJ. Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions. Mol Carcinog 2:22-26, 1989.
112. Alcaraz A, Takahashi S, Brown JA, et al. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer Cancer Res 54 3998-4002, 1994.
113. Osella P, Carlson A, Wyandt H, Milunsky A. Cytogenetic studies of eight squamous cell carcinomas of the head and neck. Deletion of 7q, a possible primary chromosomal event. Cancer Genet Cytogenet 59 73-78, 1992
114. Lundgren R, Kristoffersson U, Heim S, Mandahl N, Mitelman F. Multiple structural chromosome rearrangements, including del(7q) and del(10q), in an actenocarcinoma of the prostate Cancer Genet Cytogenet 35:103-108, 1988.
115. Balaban GB, Herlyn M, Clark WH Jr, Nowell PC. Karyotypic evolution in human malignant melanoma Cancer Genet Cytogenet 19 113-122, 1986.
116. Kacker RK, Giovanella BC, Pathak S Consistent karyotypic abnormalities in human malignant melanomas. Anticancer Res 10 859-871, 1990
117. Nibert M, Heim S Uterine leiomyoma cytogenetics. Genes Chromosom Cancer 2.3-13, 1990.
118. Ozisik YY, Meloni AM, Surti U, Sandberg AA Deletion 7q22 in uterine leiomyoma A cytogenetic review Cancer Genet Cytogenet 71:1-6, 1993.
119. Atkin NB, Baker MC Chromosome 7q deletions. Observations on 13 malignant tumors. Cancer Genet Cytogenet 67:123-125, 1993
120. Pedersen B, Ellegaard J A factor encoded by 7q31 suppresses expansion of the 7q- clone and delays cytogenetic progression. Cancer Genet Cytogenet 78:181-188, 1994
121. Gallion HH, Powell DE, Morrow JK, et al Molecular genetic changes in human epithelial ovarian malignancies Gynecologic Oncology 47:137-142, 1992.
122. Nawroz H, van der Riet P, Hruban RH, et al Allelotype of head and neck squamous cell carcinoma. Cancer Res 54:1152-1155, 1994
123. Bièche I, Champème MH, Matifas F, et al. Loss of heterozygosrty of the L-myc oncogene in human breast tumors. Lancet 339:139-143, 1992.
124. Deng GR, He LW, Lin BY. Loss of heterozygosity at different chromosomes in patients with breast cancer. Chung Hua I Hsueh Tsa Chih 74:31-34, 63-64, 1994.
125. Neuman WL, Rubin CM, Rios RB, et al Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders. Blood 79:1501-1510, 1992.
126. n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer Proc Natl Acad Sci USA 91:12155-12158, 1994
127. Cliby W, Ritland S, Hartman L, et al Human epithelial ovarian cancer allelotype Cancer Res 53.2393-2398, 1993.
128. Sato T, Saito H, Morita R, Koi S, Lee JH, Nakamura Y. Allelotype of human ovarian cancer. Cancer Res 51:5118-5122, 1991.
129. Zenklusen JC, Weitzel JN, Ball H, Conti CJ. Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene Oncogene 11.359-363, 1995
130. Zenklusen JC, Thompson JC, Klein-Szanto AJP, Conti CJ. Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1. Evidence for a broad range tumor suppressor gene Cancer Res 55:1347-1350, 1995.
131. Zenklusen JC, Thompson JC, Troncoso P, Kagan J, Conti JC. Loss of heterozygosity in human primary prostate carcinomas: A possible tumor suppressor gene at 7q31.1. Cancer Res 54:6370-6373, 1994
132. Ranzani GN, Renault B, Pellegata NS, et al. Loss of heterozygosity and K-ras gene mutations in gastric cancer. Hum Genet 92.244-249, 1993.
133. Kuniyasu H, Yasui W, Yokozaki H, et al. Frequent loss of heterozygosity of the long arm of chromosome 7 is closely associated with progression of human gastric carcinomas. Int J Cancer 59 597-600, 1994.
134. Kemp JP, Fee F, Balmain A Allelotype analysis of mouse skin tumors using polymorphic microsatellites. Sequential genetic alterations on chromosomes 6, 7, and 11 Cancer Res 53:6022-6027, 1993
135. Miyamoto S, Sasaki M, Nishida M, Wake N. Identification of a chromosome carrying a putative tumor suppressor gene in human choriocarcinoma by microcell-mediated chromosome transfer. Hum Cell 4.38-43, 1991
136. Annab LA, Dong JT, Futreal PA, et al Growth and transformation suppressor genes for BHK Syrian hamster cells on human chromosomes 1 and 11 Mol Carcinog 6 280-288, 1992.
137. Yoshida MA, Shimizu M, Ikeuchi T, et al. In vitro growth suppression and morphological change in a human renal cell carcinoma cell line by the introduction of normal chromosome 3 via microcell fusion Mol Carcinog 9:114-121, 1994.
138. Ogata T, Ayusawa D, Namba M, et al. Chromosome 7 suppresses indefinite division of nontumorigenic immortalized human fibroblast cell lines KMST-6 and SUSM-1. Mol Cell Biol 13 6036-6043, 1993.
139. Zenklusen JC, Oshimurs M, Barrett JC, Conti CJ. Inhibition of tumorigenicity of a murine squamous cell carcinoma (SCC) cell line by a putative tumor suppressor gene on human chromosome 7 Oncogene 9:2817-2825, 1994
140. Schweinfest CW, Henderson KW, Suster S, Kondoh N, Papas TS. Identification of a colon mucosa gene that is down-regulated in colon adenomas and adenocarcinomas. Proc Natl Acad Sci USA 90:4166-4170, 1993.
141. Taguchi T, Testa JR, Papas TS, Schweinfest C. Localization of a candidate tumor suppressor gene (DRA) to 7q22-q31.1 by fluorescence in situ hybridization. Genomics 20:146-147, 1994.
142. Mittelman F. Catalog of Chromosome Aberrations in Cancer, 4th Edition, Vol. 1. John Wiley & Sons, Inc., New York, 1991.